• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis.小儿NF2、SMARCB1和LZTR1相关神经鞘瘤病的癌症及中枢神经系统肿瘤监测最新进展
Clin Cancer Res. 2025 Apr 14;31(8):1400-1406. doi: 10.1158/1078-0432.CCR-24-3278.
2
Genetic findings in people with schwannomas who do not meet clinical diagnostic criteria for -related schwannomatosis.神经鞘瘤患者的遗传学发现,这些患者不符合相关神经鞘瘤病的临床诊断标准。
J Med Genet. 2024 Oct 23;61(11):1011-1015. doi: 10.1136/jmg-2024-110217.
3
Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.多发性非真皮神经鞘瘤患者中 NF2 嵌合体和神经鞘瘤病的表型和基因型重叠。
Hum Genet. 2018 Jul;137(6-7):543-552. doi: 10.1007/s00439-018-1909-9. Epub 2018 Jul 13.
4
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.小儿神经纤维瘤病 2 型和相关疾病的癌症和中枢神经系统肿瘤监测。
Clin Cancer Res. 2017 Jun 15;23(12):e54-e61. doi: 10.1158/1078-0432.CCR-17-0590.
5
Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.针对神经纤维瘤病 2 型、雪旺细胞瘤病和脑膜瘤病的靶向下一代测序进行鉴别诊断。
Neuro Oncol. 2018 Jun 18;20(7):917-929. doi: 10.1093/neuonc/noy009.
6
Schwannomatosis: a genetic and epidemiological study.神经鞘瘤病:一项遗传学和流行病学研究。
J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1215-1219. doi: 10.1136/jnnp-2018-318538. Epub 2018 Jun 16.
7
Sporadic vestibular schwannoma: a molecular testing summary.散发性前庭神经鞘瘤:分子检测总结。
J Med Genet. 2021 Apr;58(4):227-233. doi: 10.1136/jmedgenet-2020-107022. Epub 2020 Jun 23.
8
Neurofibromatosis type 2-related schwannomatosis - An update.2型神经纤维瘤病相关的神经鞘瘤病——最新进展
Semin Pediatr Neurol. 2024 Dec;52:101171. doi: 10.1016/j.spen.2024.101171. Epub 2024 Nov 9.
9
Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities.多平台分子分析揭示了与神经纤维瘤病2型相关的前庭神经鞘瘤的两个分子亚组,它们具有不同的肿瘤微环境和治疗易感性。
Acta Neuropathol. 2025 May 9;149(1):47. doi: 10.1007/s00401-025-02883-6.
10
The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.神经鞘瘤病的分子发病机制,即多个肿瘤抑制基因共同参与肿瘤发生的范例。
Hum Genet. 2017 Feb;136(2):129-148. doi: 10.1007/s00439-016-1753-8. Epub 2016 Dec 5.

引用本文的文献

1
SMARCB1-related schwannomatosis and other SMARCB1-associated phenotypes: clinical spectrum and molecular pathogenesis.与SMARCB1相关的神经鞘瘤病及其他与SMARCB1相关的表型:临床谱与分子发病机制
Fam Cancer. 2025 Aug 12;24(3):64. doi: 10.1007/s10689-025-00486-4.
2
Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions.儿童癌症易感性与监测最新进展:总结观点与未来方向
Clin Cancer Res. 2025 Jul 1;31(13):2581-2588. doi: 10.1158/1078-0432.CCR-25-0423.

本文引用的文献

1
Update on Whole-Body MRI Surveillance for Pediatric Cancer Predisposition Syndromes.儿童癌症易感性综合征的全身 MRI 监测进展。
Clin Cancer Res. 2024 Nov 15;30(22):5021-5033. doi: 10.1158/1078-0432.CCR-24-1374.
2
Heterozygosity for loss-of-function variants in LZTR1 is associated with isolated multiple café-au-lait macules.LZTR1 失活功能变异的杂合性与孤立性多发性咖啡牛奶斑相关。
Genet Med. 2024 Nov;26(11):101241. doi: 10.1016/j.gim.2024.101241. Epub 2024 Aug 10.
3
Phenotypic Expansion of Autosomal Dominant -Related Disorders with Special Emphasis on Adult-Onset Features.常染色体显性遗传疾病表型扩展,特别强调成人发病特征。
Genes (Basel). 2024 Jul 13;15(7):916. doi: 10.3390/genes15070916.
4
-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study.神经鞘瘤病及其他神经鞘瘤病相关:一项更新的遗传和流行病学研究。
J Med Genet. 2024 Aug 29;61(9):856-860. doi: 10.1136/jmg-2024-110065.
5
Brigatinib in -Related Schwannomatosis with Progressive Tumors.布加替尼治疗相关进行性肿瘤性神经鞘瘤病。
N Engl J Med. 2024 Jun 27;390(24):2284-2294. doi: 10.1056/NEJMoa2400985. Epub 2024 Jun 21.
6
Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis.NF2 相关神经鞘瘤病患者的血管内皮生长因子受体疫苗的 I/II 期研究。
J Clin Oncol. 2024 Jul 20;42(21):2578-2587. doi: 10.1200/JCO.23.02376. Epub 2024 May 22.
7
Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors.癌症易感性综合征的最新进展及儿童脑肿瘤监测指南。
Clin Cancer Res. 2024 Jun 3;30(11):2342-2350. doi: 10.1158/1078-0432.CCR-23-4033.
8
Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression.神经纤维瘤病2型相关神经鞘瘤病中良性肿瘤的放射治疗:一项对266例接受放疗患者的全国性研究显示恶性肿瘤/恶性进展显著增加。
Neurooncol Adv. 2023 Mar 11;5(1):vdad025. doi: 10.1093/noajnl/vdad025. eCollection 2023 Jan-Dec.
9
Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.多中心、前瞻性、II 期研究:贝伐珠单抗维持治疗 NF2 相关听神经鞘瘤和进行性前庭神经鞘瘤患儿及成人。
Neuro Oncol. 2023 Aug 3;25(8):1498-1506. doi: 10.1093/neuonc/noad066.
10
Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis.与2型神经纤维瘤病相关的神经鞘瘤病高危个体的基因检测、筛查及临床管理更新方案
Clin Genet. 2023 May;103(5):540-552. doi: 10.1111/cge.14310. Epub 2023 Mar 15.

小儿NF2、SMARCB1和LZTR1相关神经鞘瘤病的癌症及中枢神经系统肿瘤监测最新进展

Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis.

作者信息

Perrino Melissa R, Jongmans Marjolijn C J, Tomlinson Gail E, Greer Mary-Louise C, Scollon Sarah R, Mitchell Sarah G, Hansford Jordan R, Schultz Kris Ann P, Kohlmann Wendy K, Kalish Jennifer M, MacFarland Suzanne P, Das Anirban, Maxwell Kara N, Pfister Stefan M, Weksberg Rosanna, Michaeli Orli, Tabori Uri, Ney Gina M, Lupo Philip J, Brzezinski Jack J, Stewart Douglas R, Woodward Emma R, Kratz Christian P

机构信息

Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

出版信息

Clin Cancer Res. 2025 Apr 14;31(8):1400-1406. doi: 10.1158/1078-0432.CCR-24-3278.

DOI:10.1158/1078-0432.CCR-24-3278
PMID:39937237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12002630/
Abstract

Schwannomatosis (SWN) is a distinct cancer predisposition syndrome caused by germline pathogenic variants in the genes NF2, SMARCB1, or LZTR1. There is a significant clinical overlap between these syndromes with the hallmark of increased risk for cranial, spinal, and peripheral schwannomas. Neurofibromatosis type 2 was recently renamed as NF2-related SWN and is the most common SWN syndrome, with increased risk for bilateral vestibular schwannomas, intradermal schwannomas, meningiomas, and less commonly, ependymoma. SMARCB1-related SWN is a familial SWN syndrome associated with peripheral and spinal schwannomas and an increased risk for meningiomas and malignant peripheral nerve sheath tumors, even in the absence of radiation. These individuals do not develop bilateral vestibular schwannomas. Finally, patients with LZTR1-related SWN typically present with peripheral schwannomas, and unilateral vestibular schwannomas have been reported. The following perspective is intended to highlight the clinical presentation and international tumor surveillance recommendations across these SWN syndromes.

摘要

神经鞘瘤病(SWN)是一种由NF2、SMARCB1或LZTR1基因种系致病性变异引起的独特的癌症易感性综合征。这些综合征之间存在显著的临床重叠,其特征是患颅神经鞘瘤、脊神经鞘瘤和周围神经鞘瘤的风险增加。2型神经纤维瘤病最近被重新命名为NF2相关的SWN,是最常见的SWN综合征,双侧前庭神经鞘瘤、皮内神经鞘瘤、脑膜瘤的患病风险增加,室管膜瘤则较少见。SMARCB1相关的SWN是一种家族性SWN综合征,与周围神经鞘瘤和脊神经鞘瘤有关,即使在没有辐射的情况下,患脑膜瘤和恶性周围神经鞘膜瘤的风险也会增加。这些个体不会发生双侧前庭神经鞘瘤。最后,LZTR1相关SWN的患者通常表现为周围神经鞘瘤,并且有单侧前庭神经鞘瘤的报道。以下观点旨在强调这些SWN综合征的临床表现和国际肿瘤监测建议。